The integration of Cell Therapy and AI has resulted in improved diagnoses and patient outcomes and has added value/financial benefits to those companies who have combined these advanced technologies in pursuit of quality healthcare. AI brings radical innovation for those wanting to take a leadership role in BioPharma/Pharma 4.0.